It has become evident that GNBT has not retained medical, legal, securities and p.r. teams that know what is needed to navigate the complex landscape to get drug testing authorized, i. p.o. launch procedures, financing and partnering agreements, shareholder relations, quarterly and annual reporting of a complex multi-dimensional holding company and more. At least this is what I see, otherwise why would each and every key initiative seemingly get sucked into a black hole of silence. Just an opinion, not based on direct observation.